Brian R. Weston, MD

Peer-Reviewed Articles

1. Salem, AE, Ramirez, S, Weston, B, Hussein, A, Krebs, SS. Case Report. Frontiers in Medicine 13, 2026. e-Pub 2026. PMID: 41695167.
2. Nakshabandi AA, Ali FS, Albustami I, Hwang H, Qiao W, Johnston NC, Shaikh AS, Coronel E, Ge PS, Ross W, Weston BR, Lee JH. Biliary Drainage in Hilar and Perihilar Cholangiocarcinoma; 25-Year Experience at a Tertiary Cancer Center. Gastrointest Endosc 99(6):938 -949, 2024. e-Pub 2024. PMID: 38092128.
3. Sewastjanow-Sliva M, Xiao L, Gonzalez GN, Wang X, Hofstetter W, Swisher S, Mehran R, Sepesi B, Bhutani MS, Weston B, Coronel E, Waters RE, Rogers JE, Smith J, Lyons L, Reilly N, Yao JC, Ajani JA, Murphy MB. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study. Cancers 16(7):1378, 2024. e-Pub 2024. PMID: 38611046.
4. Sewastjanow-SilvaM, Xiao L, Gonzalez GN, Wang X, Hofstetter W, Swisher S, Mehran R, Sepesi B, Bhutani MS, Weston B, Coronel E, Waters RE, Rogers JE, Smith J, Lyons L, Reilly N, Yao JC, Ajani JA, Murphy MB. Chemotherapy plus Atezolizumab pre- and post-resection in localized esophageal or gastroesophageal junction adenocarcinomas: a phase I/II single-arm study. Cancer (Basel) 16(7):1378, 2024. e-Pub 2024. PMID: 38611056.
5. Weston BR. Pancreatic steatosis: Identification of yet another "new" modifiable high-risk factor for post-ERCP pancreatitis?. Gastrointest Endosc 99(2):224 - 226, 2024. e-Pub 2024. PMID: 38237965.
6. Kyle G Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg 117(2):320 - 326, 2024. e-Pub 2024. PMID: 37080372.
7. Pabon, CM, Xiao, L, Badgwell, BD, Mansfield, PF, Ikoma, N, Sewastjanow-Silva, M, Lee, JH, Bhutani, M, Weston, B, Coronel, E, Smith, GL, Holliday, EB, Tian, J, Das, P, Minsky, B, Waters, R, Estrella, JS, Li, JJ, Ajani, JA, Blum Murphy, M. Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma. Journal of Clinical Oncology 42(16), 2024. e-Pub 2024.
8. Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg S0003(4975(23)):00395 - 8, 2023. e-Pub 2023. PMID: 37080372.
9. Vassilakopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros A, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee J H, Weston BR, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JA. Localized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment?. Oncology (Switzerland) 101(3):153 - 158, 2023. e-Pub 2023. PMID: 36412619.
10. Gan Q, Roy-Chowdhuri S, Duose DY, Stewart JM, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra A. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound–guided FNA and FNB. Cancer Cytopathology 130(4):275 - 283, 2022. e-Pub 2022. PMID: 34905283.
11. Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, JH| L, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. Correction to: Lnc RNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer 20(1):56, 2021. e-Pub 2021. PMID: 33766033.
12. Lee JJ, Bernard V, Semaan A, Monberg ME, Huang J, Stephens BM, Lin D, Rajapakshe KI, Weston BR, Bhutani MS, Haymaker CL, Bernatchez C, Taniguchi CM, Maitra A, Guerrero PA. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clin Cancer Res 27(21):5912-5921, 2021. e-Pub 2021. PMID: 34426439.
13. Weston BR, Patel JM, Pande M, Lum PJ, Ross WA, Gottumukkala RS, Lynch PM, Coronel E, Ge PS, Lee JH. Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstruction. Surg Endosc 35(8):4511-4519, 2021. e-Pub 2021. PMID: 32909212.
14. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and implications of paratracheal lymph node metastases in resectable esophageal or gastroesophageal junction adenocarcinoma. Ann Surg 273(4):751-757, 2021. e-Pub 2021. PMID: 31188215.
15. Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, E JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JA. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut 70(12):2238 - 2248, 2021. e-Pub 2021. PMID: 33487592.
16. Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Murphy MB, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Sone S, Wang L, Ajani JA. Intergrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut, 2020. e-Pub 2020. PMID: 33334899.
17. Semaan A, Bernard V, Lee JJ, Wong JW, Huang J, Swartzlander DB, Stephens BM, Monberg ME, Weston B, Bhutani MS, Chang K, Scheet P, Maitra A, Jakubek YA, Guerrero PA. Defining the Comprehensive genomic landscapes of pancreatic ductal adenocarcinoma using real world endoscopy aspiration samples. Clin Cancer RRes, 2020. e-Pub 2020. PMID: 33188144.
18. Hagan KB, Carlson R, Arnold B, Nguyen L, Lee JH, Weston B, Hernandez M, Feng L, Syed T, Hagberg CA. Safety of the LMA Gastro for endoscopic retrograde cholangiopancreatography. Anesth Analg 131(5):1566-1572, 2020. e-Pub 2020. PMID: 33079880.
19. Weston BW, Swingen ZN, Gramann S, Pojar D. SAFER model: Strategic allocation of fundamental epidemic resources. J Public Health (Oxf), 2020. e-Pub 2020. PMID: 33161436.
20. Cazacu IM, Singh BS, Chavez AAL, Koduru P, Ejaz S, Weston BR, Ross WA, Lee JH, Roy-Chowdhuri S, Bhutani MS. EUS and EUS-guided FNA/core biopsies in the evaluation of subepithelial lesions of the lower gastrointestinal tract:10-year experience. Endosc Ulatrasound, 2020. e-Pub 2020. PMID: 32913150.
21. Harada K, Hwang Y, Wang X, Abdelhakeem A, Iwatsuki M, Blum-Murphy MA, Maru DM, Weston B, Lee, JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das Prajnan D, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer 23(5):904-912, 2020. e-Pub 2020. PMID: 32347396.
22. Angsuwatcharakon P, Ahmed O, Lynch PM, Lum P, Gonzalez GN, Weston B, Coronel E, Katz MHG, Folloder J, Lee JH. Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary referral center. Gastrointest Endosc 92(2):323-330, 2020. e-Pub 2020. PMID: 32145286.
23. Harada K, Wu CC, Wang X, Kaya DM, Amlashi FG, Iwatsuki M, Blum-Murphy MA, Maru DM, Weston B, Lee JH, Rogers JA, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA. Total lesion glycolysis Assessment identifies a patient fraction with a high cure rate among esophageal adenocarcinoma patients treated with definitive chemoradiation. Ann Surg 272(2):311-318, 2020. e-Pub 2020. PMID: 32675544.
24. Song S, Li Y, Yan X, Lang M, Pizzi MP, Lin J, Scott AW, Huo L, Wang Y, Lee JH, Bhutani MS, Weston BR, Shanbhag ND, Johnson RL, Ajani JA. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Mol Oncol 14(6):1410-1426, 2020. e-Pub 2020. PMID: 32175692.
25. Kaya DM, Gonzalez GMN, Harada K, Blum-Murphy, Lee JH, Bhutania MS, Weston B, Thomas I, Rogers JE, Das P, Badgwell BD, Ajani JA. Efficacy of three-drug induction chemotherapy allowed by preoperative chemoradiation in patients with localized gastric adenocarcinoma. Oncology 98(8):542-548, 2020. e-Pub 2020. PMID: 32434189.
26. Harada K, Patnana M, Wang X, Iwatsuki M, Murphy MAP, Zhao M, Das P, Minsky BD, Weston B, Lee JH, Bhutani MD, Estrella JS, Shanbhag N, Ikoma N, Badgwell BD, Ajani JA. Low metabolic activity in primary gastric andeocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells. Surg Today(50):1223-1231, 2020. e-Pub 2020. PMID: 32409870.
27. Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen Q, Ajani JA. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine 99(9):e19295, 2020. e-Pub 2020. PMID: 32118743.
28. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee JH, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davilla M, Stroehlein J. Cap-fitted endoscopic mucosal resection of 20mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 2:E115-E121, 2020. e-Pub 2020. PMID: 32010742.
29. Angsuwatcharakon P, Singh BS, Cazacu IM, Weston BR, Bhutani MS. Difficult pyloric intubation during EUS: forward viewing echoendoscope to the rescue (with videos). Endosc Ultrasound, 2019. e-Pub 2019. PMID: 31854345.
30. Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, Lee JH, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. LncRNA PVT 1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer(18):141, 2019. e-Pub 2019. PMID: 31601234.
31. Abu-Sbeih H, Chen E, Ahmed O, Mallepally N, Lum P, Qiao W, Lee HJ, Bresalier R, Wang LS, Weston B, Raju GS, Wang Y. Patients with Non-Hodgkin’s Lymphoma are at risk of adenomatous colon polyps. Dig Dis Sci(64):2965-2971, 2019. e-Pub 2019. PMID: 31053975.
32. Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MS. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endoscopic Ultrasound. Endoscopic Ultrasound, 2019. e-Pub 2019. PMID: 31552914.
33. Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, Lee JH, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. Mediastinal nodal involvement after neoadjuvant chemoradiation for Siewert II/III adenocarcinoma. Ann Thorac Surg(108):845-851, 2019. e-Pub 2019. PMID: 31102632.
34. Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR. Computed tomography-based biomarker outcomes in a prospective trial of preoperative FOLFFIRINOX and Chemoradiation for borderline resectable pancreatic cancer. JCO Precis Oncol, 2019. e-Pub 2019. PMID: 32914036.
35. Koay EJ, Katz MHG, Wang H, Wang X, Prakas L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Anirban M, Wolff RA, Varadhachary. FOLFIRINOX and chemoration for borderline resectable pancreatic cancer. JCO Precis Oncol, 2019. e-Pub 2019. PMID: 32914036.
36. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg(108):845-851, 2019. e-Pub 2019. PMID: 31188215.
37. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MD, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal nodal involvement after Neoadjuvant chemoradiation for Siewert II.III adenocarcinoma. Thorac Surg(108):845-851, 2019. e-Pub 2019. PMID: 31102632.
38. Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL. Should endoscopic mucosal resection be attempted for CT2N0 esophageal cancer. Dis esophagus. Dis esophagus, 2019. e-Pub 2019. PMID: 3088418.
39. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20 mm colon polyps. Endosc Int Open(7):E361-E366, 2019. e-Pub 2019. PMID: 30834295.
40. Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wolff RA, Varadhachary GR. First-line gemcitabine and Nab-Paclitaxel Chemotherapy for localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol(26):619-627, 2019. e-Pub 2019. PMID: 30324485.
41. Cassani LS, Chouhan J, Chan C, Lanke G, Chen HC, Wang X, Weston B, Ross WA, Raju GS, Lee JH. Biliary decompression in perihilar cholangiocarcinoma improves survival: a single center retrospective analysis. Dig Dis Sci(64):561-569, 2019. e-Pub 2019. PMID: 30238201.
42. Lee JH, Emelogu I, Kukreja K, Ali FS, Nogueras-Gonzalez G, Lum P, Coronel E, Ross W, Raju GS, Lynch P, Thirumurthi S, Stroehlein J, Wang Y, You YN, Weston B. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc, 2019. e-Pub 2019. PMID: 30797835.
43. Mizrak KD, Nogueras-Gonzales GM, Harada K, Amlashi FG, THomis I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Jr MA, Devine CE, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma treated without surger. Eur J Cancer 98:23-29, 2018. e-Pub 2018. PMID: 29859338.
44. Amiashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett’s esophagus after bimodality therapy in patients with esophageal adenocarcinoma. Oncology 95(2):81-90, 2018. e-Pub 2018. PMID: 29843157.
45. Elimova E, Wang X, Qiao, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee JH, Weston BR, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Rogers JE, Skinner HG, Maru DM, Hofstetter WL, Ajani JA. Actionable locoregional relapses after therapy of localized esophageal cancer; insights from a large cohort. Oncology 94(6):345-353, 2018. e-Pub 2018. PMID: 29705797.
46. DaVee T, Coronel E, Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Nogueras González GM, Bhutani MS, Ross WA, Weston BR, Lee JH. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Gastrointest Endosc 87(6):1443-50, 2018. e-Pub 2018. PMID: 29309780.
47. Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomized trial. Br J Cancer(118):331-337, 2017. e-Pub 2017. PMID: 292355564.
48. Mizrak Kaya D, Dong X, Noguueras-Gonzalaz GM, Xu Y, Estrella JS, Harada K, Lopez A, Amiashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Post-trimodality expression levels of metadherin (MTHD) as a prognostic biomarker for esophageal adenocarcinoma patients. Med Oncol, 2017. e-Pub 2017. PMID: 28685276.
49. Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Sas P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Jr MA, Sagabiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. 101 Long-term survivors who had metastatic gastroesophageal cancer and received local consolidative therapy. Oncology, 2017. e-Pub 2017. PMID: 28683449.
50. Xi, M, Xu X, Liao Z, Hofstetter WL, Blum Murphy M, Maru DM, Bhutani MS, Lee JH, Weston B, Komaki R, Lin SH. The impact of histology on recurrence patterns in esophageal cancer treated with definitive cheomradiotherapy. Radiother Oncol, 2017. e-Pub 2017. PMID: 28687396.
51. Xi M, Hallemeier CL, Merrell KW, Liao Z, Murphy MAB, Ho L, Hofstetter WL, Mehran R, Lee JH, Bhutani MS, Weston B, Maru DM, Komaiki R, Ajani JA, Lin SH. Recurrence risk stratification after preoperative chemoradiation of esophageal adenocarcinoma. Ann Surg, 2017. e-Pub 2017. PMID: 28628563.
52. Weston BR, Ross WA, Bhutani MS, Lee JH, Pande M, Sholl AB, Krishnamurthy S. Prospective randomized comparison of a 22G core needle using standard versus capillary suction for EUS-sampling of solid pancreatic masses. Endoscopy International Open(5):E1-E8, 2017. e-Pub 2017. PMID: 28596983.
53. Shimodaira Y, Slack, RS, Harada K, Bhutani MD, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA. Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. Oncotarget, 2017. e-Pub 2017. PMID: 28611281.
54. Weston BR, Ross WA. Quality metrics: beyond adenoma detection rate. Gastrointest Endosc 85(3):588-9, 2017. e-Pub 2017. PMID: 28215769.
55. Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Pre-operative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-year single-institution experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2017. PMID: 27778257.
56. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mare J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Jr MA, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-morbidities rather than age impact outcomes in patients receving preoperative therapy for gastroesophageal adenocarcinoma. Ann Surg Oncol. e-Pub 2016. PMID: 27770339.
57. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani M, Shafi M, Weston B, Pande M, Bresalier R, Rashid A, Mishra L, Davila M, Stroehlein J. Outcomes of endoscopic mucosal resection as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc 84(2):315-25, 2016. e-Pub 2016. PMID: 27100181.
58. Charalampakis N, Nogueras Gonzalez GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Jr MA, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA. The proportion of signet ring cell component in patients with localized gastric adenocarcinoma correlates with the degree of response to pre-operative chemoradiation. Oncology 90(5):239-47, 2016. e-Pub 2016. PMID: 27046280.
59. Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shhimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Jr MA, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak KD, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic gastroesophageal adenocarcinoma patients treated with systemic therapy followed by consolidative local therapy: A nomogram associated with long-term survivors. Oncology 91(1):55-60, 2016. e-Pub 2016. PMID: 27120436.
60. Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, Li S, Lin SH, Javle M, McMurray JS, Rahlfs TF, Mishra B, White J, Rashid A, Beauchemin N, Weston BR, Shafi MA, Stroehlein JR, Davil M, Akbani R, Weinstein JN, Wu X, Mishra L. Mutational profiles reveal an aberrant TGF-b-CEA regulated pathway in colon adenomas. PLoS One 11(4):e:0153933, 2016. e-Pub 2016. PMID: 27100181.
61. Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A nomogram to predict distant metastases after multimodality therapy of patients with localized esophageal cancer. J Natl Compr Canc Netw 14(2):173-9, 2016. e-Pub 2016. PMID: 26850487.
62. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JA. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer 51(17):2545-52, 2015. e-Pub 2015. PMID: 26321501.
63. Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, Betancourt SL, Rice DC, Swisher SG, Hofstetter WL. Endoscopic ultrasound estimates for tumor depth at the gastroesophageal junction are inaccurate: implications for the liberal use of endoscopic resection. Ann Thorac Surg 100(5):1812-6, 2015. e-Pub 2015. PMID: 26233274.
64. Raju GS, Lum PJ, Slack R, Thirumurthi SI, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural Language Processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc 82(3):512-9, 2015. e-Pub 2015. PMID: 25910665.
65. Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Jr MA, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial standardized uptake value of position emission tomography influences the prognosis of patients with localized gastric adenocarcinoma treated preoperatively. Oncology 89(6):305-10, 2015. e-Pub 2015. PMID: 26393501.
66. Bektas M, Krishna SG, Ross WA, Weston B, Katz MH, Fleming JB, Lee JH, Bhutani MS. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endosc Ultrasound 4(3):219-24, 2015. e-Pub 2015. PMID: 26374580.
67. Neishaboori N, Wadhwa R, Nogueras-Gonzalez G, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee J, Bhutani M, Weston B, Blum M, Rogers J, Garris J, Rice D, Komaki R, Swisher S, Skinner H, Hofstetter W, Ajani J. Distribution of resistant esophageal adenocarcinoma in the resected specimens of clinical stage III patients after chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 2015. e-Pub 2015. PMID: 25765719.
68. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen H, Maru D, Komaki R, Lee JH, Weston BR, Bhutani M, Blum M, Skinner HD, Hofstetter W, Ajani J. Geographic distribution of regional metastatic nodes affects outcome of tri-modality-eligible patients with esophageal adenocarcinoma. Oncology 88(6):332-6, 2015. e-Pub 2015. PMID: 25765098.
69. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova EE, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120(23):3635-41, 2014. e-Pub 2014. PMID: 25091571.
70. Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 2014. e-Pub 2014. PMID: 25225435.
71. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 2014. e-Pub 2014. PMID: 25099446.
72. Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RL. Hippo coactivator YAP1 upregulates SOX9 and endows stem-like properties to esophageal cancer cells. Cancer Res. e-Pub 2014. PMID: 24906622.
73. Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Ajani JA. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology 7(86(5-6)):336-339, 2014. e-Pub 2014. PMID: 24925190.
74. Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol 8(1):142-9, 2014. e-Pub 2014. PMID: 24210755.
75. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional Failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 2013. e-Pub 2013. PMID: 24145339.
76. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 2013. e-Pub 2013. PMID: 23994746.
77. Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: Implications for screening and surveillance. Oncology 85(4):204-7, 2013. e-Pub 2013. PMID: 24051869.
78. Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation. Oncology 85(2):95-9, 2013. e-Pub 2013. PMID: 23860252.
79. Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-7, 2013. e-Pub 2013. PMID: 23799217.
80. Weston BR, Bhutani MS. Technical Review: Optimizing diagnostic yield for EUS-guided sampling of solid pancreatic lesions. Gastroenterology and Hepatology 9(6):35-63, 2013. e-Pub 2013. PMID: 23935542.
81. Krishna SG, Bhutani MS, Mosher CH, Staerkel GA, Weston BR. A first report of endoscopic ultrasound for the diagnosis of pancreatic amyloid deposition in immunoglobulin light chain (a1) amyloidosis (primary amyloidosis). JOP 14(3):283-5, 2013. e-Pub 2013. PMID: 23669481.
82. Chen WC, Weston BR, Krishna SG, Gomez G, Rashid A, Katz MH, Lee JE, Raju GS. Prolonged endoloop ligation for removal of gastrointestinal tumors. Endoscopy 45(S(02)):E69-70, 2013. e-Pub 2013. PMID: 23526523.
83. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 2012. e-Pub 2012.
84. Suzuki A, Xiao L, Taketa T, Blum MA, Jr MA, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradiation without surgery: UT MD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012. e-Pub 2012. PMID: 22677933.
85. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 2012. e-Pub 2012. PMID: 22964903.
86. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-13, 2012. e-Pub 2012. PMID: 22328056.
87. Weston BR. Mediastinal paraganglioma: EUS findings and a cautious reminder of potential risks from FNA of unknown mediastinal masses. Visible Human Journal of Endoscopy 11(2), 2012. e-Pub 2012.
88. Weston BR, Ross WA, Liu J, Lee JH. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference?. Gastrointestinal Endoscopy 72(6):1195-200, 2010. e-Pub 2010. PMID: 21111871.
89. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 116(6):1454-61, 2010. e-Pub 2010. PMID: 20143447.
90. Weston BR, Thosani N, Bektas M, Oruc N, Bhutani MS. Pill esophagitis masquerading as esophageal cancer on endoscopy and endoscopic ultrasound. Visible Human Journal of Endoscopy 2010;9(2) 9(2), 2010. e-Pub 2010.
91. Weston BR, Bhutani MS. Metastatic recurrent appendiceal adenocarcinoma to the peritoneum diagnosed by rectal endoscopic ultrasound. Visible Human Journal of Endoscopy 8(1), 2009. e-Pub 2009.
92. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography?. Cancer 112(11):2417-23, 2008. e-Pub 2008. PMID: 18404695.
93. Weston BR, Anandasabapathy S, Bhutani MS. Splenule masquerading as pancreatic neuroendocrine tumor. Visible Human Journal of Endoscopy 7(2), 2008. e-Pub 2008.
94. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, Strahl E, Rex DK. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol 98(11):2440-7, 2003. e-Pub 2003. PMID: 14638346.
95. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol 36(5):399-402, 2003. e-Pub 2003. PMID: 12702980.

Professional Educational Materials

1. Weston BR. Comparison general anesthesia versus monitored anesthesia care for ERCP in average-risk patients. Gastrointest Endosc, 2022.
2. Weston BR. Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. Gastrointest Endosc, 2022.
3. Weston BR. EUS-directed transgastric interventions in Roux-en-Y gastric bypass anatomy. Gastrointest Endosc, 2022.
4. Weston BR. Triaging advanced GI endoscopy procedures during the Covid-19 pandemic, 2022.
5. Weston BR. Cold versus hot snare resection with or without submucosal injection of 6 to 15mm colorectal polyps. Gastrointest Endosc, 2022.
6. Weston BR. Endoscopic gastric plication for treatment of weight regain following Roux-en-Y gastric bypass. Gastrointest Endosc, 2022.
7. Weston BR. Understand the diagnostic performance of end-cutting fine-needle biopsy needles for endoscopic ultrasound tissue sampling of solid pancreatic masses. Gastrointest Endosc, 2022.
8. Weston BR. Implications of stable or increasing adenoma detection rate on your need for continuous measurement. Gastrointest Endosc, 2022.
9. Weston BR. Evaluation in real-time use of artificial intelligence during colonoscopy to predict ulcerative colitis relapse. Gastrointest Endosc, 2022.
10. Weston BR. Safety and efficacy of a novel resection system for direct endoscopic necrosectomy of walled-off pancreas necrosis. Gastrointest Endosc, 2022.
11. Weston BR. Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events during screening colonoscopy. Gastrointest Endosc, 2022.
12. Weston BR. CDNA methylation markers for the diagnosis of cholangiocarcinoma in ERCP-based brush cytology. Gastrointest Endosc, 2022.
13. Weston BR. Detection of elusive polyps via a novel large-scale artificial intelligence system. Gastrointest Endosc, 2021.
14. Weston BR. Safety and efficacy of endoscopic versus surgical gastrojejunal revision for weight regain in Roux-en-Y gastric bypass patients. Gastrointest Endosc, 2021.
15. Weston BR. Pancreatic cyst fluid glucose for the diagnosis of mucinous versus nonmucinous pancreatic cysts. Gastrointest Endosc, 2021.
16. Weston BR. Outcomes of pyloric dilation with the esophageal function lumen imaging probe (EsoFLIP) controlled dilation for the management of gastroparesis. Gastrointest Endosc, 2021.
17. Weston BR. Outcomes of combined endoscopic mucosal resection (EMR) and full-thickness resection (FTR) for colorectal polyps not amenable to removal by standard techniques. Gastrointest Endosc, 2021.
18. Weston BR. Duodenal mucosal resurfacing combined with GLP-1RA to discontinue insulin in type 2 diabetes. Gastrointest Endosc, 2021.
19. Weston BR. Outcomes of POEM with short versus standard myotomy for treatment-naïve patients with type II achalasia. Gastrointest Endosc, 2021.
20. Weston BR. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions. Gastrointest Endosc, 2021.
21. Weston BR. Safety and effectiveness of peroral endoscopic myotomy in patients on antiplatelet or anticoagulant therapy. Gastrointest Endosc, 2021.
22. Weston BR. Real-time artificial intelligence - based histological classification of colorectal polyps with augmented visualization. Gastrointest Endosc, 2021.
23. Weston BR. A deep convolutional neural network system for diagnosing gastroesophageal varices and predicting risk of rupture. Gastrointest Endosc, 2021.
24. Weston BR. Outcomes of revisional endoscopic sleeve gastroplasty after laparoscopic sleeve gastrectomy. Gastrointest Endosc, 2021.
25. Weston BR. Long-term outcomes of fully covered self-expanding metal stents for benign biliary stricture after orthotopic liver transplant. Gastrointest Endosc, 2020.
26. Weston BR. Outcomes of anterograde EUS-guided pancreatic duct drainage in patients with benign obstructive pancreatopathy. Gastrointest Endosc, 2020.
27. Weston BR. Classification and relevance of false positive results during computer-aided detection-assisted colonoscopy. Gastrointest Endosc, 2020.
28. Weston BR. Triaging advanced GI endoscopy procedures during the COVID-19 pandemic. Gastrointest Endosc, 2020.
29. Weston BR. The effect of a quality improvement program on adenoma detection rate and interval colorectal cancer rate. Gastrointest Endosc, 2020.
30. Weston BR. Automatic detection of small-bowel lesions by wireless capsule endoscopy using artificial intelligence. Gastrointest Endosc, 2020.
31. Weston BR. Costs of prophylactic clip closure after endoscopic resection of large colon polyps. Gastrointest Endosc, 2020.
32. Weston BR. Transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc, 2020.
33. Weston BR. Prediction of high malignancy potential gastric gastrointestinal stromal tumors (GISTs) before endoscopic resection. Gastrointest Endosc, 2020.
34. Weston BR. Risk of developing metachronous advanced colorectal neoplasia after resection of low risk diminutive versus small adenomas. Gastrointest Endosc, 2020.
35. Weston, BR. Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events during screening colonoscopy. Gastrointest Endosc, 2020.
36. Weston, BR. Linked color imaging versus narrow-band imaging for colorectal polyp detection. Gastrointest Endosc, 2020.
37. Weston BR. Predictive value of endoscopic appearance of the major papilla for difficult bile duct cannulation during ERCP. Gastrointest Endosc, 2019.
38. Weston BR. Endoscopic sleeve gastroplasty for the management of overweight and obese patients. Gastrointest Endosc, 2019.
39. Weston BR. Peroral endoscopic myotomy (POEM) versus Heller myotomy (HM) for the treatment of achalasia. Gastrointest Endosc, 2019.
40. Weston BR. The association of small versus diminutive adenomas and the risk for metachronous advanced adenomas. Gastrointest Endosc, 2019.
41. Weston BR. The effect of video monitor size on polyp detection during screening colonoscopy. Gastrointest Endosc, 2019.
42. Weston BR. Risk factors for early and late adenoma recurrence after resection of advanced colorectal polyps, 2019.
43. Weston BR. Short-term outcomes of endoscopic sleeve gastrectomy. Gastrointest Endosc, 2019.
44. Weston BR. Risk factors and clinical prediction tools for adverse outcomes in severe acute lower GI bleeding. Gastrointest Endosc, 2019.
45. Weston BR. Chronic pancreatitis changes on screening EUS in high-risk individuals for pancreatic cancer. Gastrointest Endosc, 2019.
46. Weston BR. Diagnostic yield and miss rate of the EndoRings attachment device during colonoscopy in FIT positive patients. Gastrointest Endosc, 2019.
47. Weston BR. EUS-guided sampling with a 20-gauge fine-needle biopsy device versus a 25-gauge fine-needle aspiration device. Gastrointest Endosc, 2019.
48. Weston BR. EUS-guided celiac ganglion radiofrequency ablation (RFA) versus celiac plexus neurolysis (CPN) for palliation of pain in pancreatic cancer. Gastrointest Endosc, 2019.
49. Br W. Fully covered self-expandable metal stents to dilate persistent pancreatic duct strictures in chronic pancreatitis: long term follow-up from a prospective study. Gastrointest Endosc, 2018.
50. Weston BR. The impact of computerized feedback during simulation based-colonoscopy training. Gastrointest Endosc, 2018.
51. Weston BR. The impact of water exchange technique during screening colonoscopy. Gastrointest Endosc, 2018.
52. Weston B. Endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy. Gastrointest Endosc, 2018.
53. Weston BR. Covered versus uncovered self-conformable metal stents for palliation of primary malignant extrahepatic biliary strictures. Gastrointest Endosc, 2018.
54. Weston BR. EUS versus ERCP for primary biliary decompression in pancreatic cancer. Gastrointest Endosc, 2018.
55. Weston BR. Clinical outcomes and factors associated with stent-related colon perforation in patients with malignant obstructio. Gastrointest Endosc, 2018.
56. Weston BR. Through-the-needle microforceps biopsies for the sampling of pancreatic cystic lesions during EUS. Gastrointest Endosc, 2018.
57. Weston BR. Gastroesophageal reflux disease after per-oral endoscopic myotomy versus Heller’s myotomy for achalasia. Gastrointest Endosc, 2018.
58. Weston BR. Colon capsule endoscopy for colorectal neoplasia screening in patients with a family history of colorectal cancer. Gastrointest Endosc, 2018.
59. Weston BR. Endoscopic treatment of fistulas after sleeve gastrectomy; a comparison of internal drainage versus closure. Gastrointest Endosc, 2018.
60. Weston BR. Endoscopic sphincterotomy for the management of sphincter of Oddi dysfunction. Gastrointest Endosc, 2018.
61. Weston BR. Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis. Gastrointest Endosc, 2017.
62. Weston BR. Colorectal cancer screening with the fecal immunochemical test (FIT) for individual less than 50 years of age. Gastrointest Endosc, 2017.
63. Weston BR. . Endoscopic submucosal dissection (ESD) for Barrett’s early neoplasia. Gastrointest Endosc, 2017.
64. Weston BR. EUS-guided fine-needle biopsy (FNB) with a novel fork-tip needle versus standard fine-needle aspiration (FNA) needle for the sampling of suspected gastrointestinal stromal tumors (GISTs). Gastrointest Endosc, 2017.
65. Weston BR. Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy. Gastrointest Endosc, 2017.
66. Weston BR. EUS-guided FNA for the diagnosis of remote malignant intravascular thrombi. Gastrointest Endosc, 2017.
67. Weston BR. Indomethacin and diclofenac for the prevention of post-ERCP pancreatitis. Gastrointest Endosc, 2017.
68. Weston BR. Guidelines for the surgical management of pancreatic cysts. Gastrointest Endosc, 2017.
69. Weston BR. Fully covered self-expanding metal stents versus lumen-apposing fully covered self-expanding metal stents versus double-pigtail plastic stents for endoscopic drainage of pancreatic walled-off necrosis. Gastrointest Endosc, 2017.
70. Weston BR. Non-neoplastic polypectomy rates and high-quality colorectal cancer screening colonoscopy. Gastrointest Endosc, 2017.
71. Weston BR. Predictors of outcomes in patient undergoing covered and uncovered self-expandable metal stent placement for malignant gastric outlet obstruction. Gastrointest Endosc, 2017.
72. Weston BR. CME-Rectal indomethacin for the prevention of post-ERCP pancreatitis. Gastrointest Endosc, 2017.
73. Weston BR. CME-Factors predicting adverse events associated with therapeutic colonoscopy, 2016.
74. Weston BR. CME-Diagnosis of autoimmune pancreatitis by EUS-guided FNA with a 22-gauge needle. Gastrointest Endosc, 2016.
75. Weston BR. CME-Single-session laparoscopic cholecystecomty and ERCP for the management of choledocholithiasis. Gastrointest Endosc, 2016.
76. Weston BR. CME-Predication of malignancy and long-term outcomes of branch-duct intraductal papillary mucinous neoplasms. Gastrointest Endosc, 2016.
77. Weston BR. CME-EUS-guided FNA biospy for the diagnosis of autoimmune pancreatitis. Gastrointest Endosc, 2016.
78. Weston BR. CME-The risk of pancreatic cancer in patients with pancreatic cysts. Gastrointest Endosc, 2016.
79. Weston BR. CME-Fluorescence in situ hybridization (FISH) compared with conventional cytology for the diagnosis of malignant biliary strictures. Gastrointest Endosc, 2016.
80. Weston BR. CME-EUS-guided ethanol lavage for the treatment of pancreatic cystic neoplasm. Gastrointest Endosc, 2016.
81. Weston BR. CME-The prevalence of advanced histoglogical features and synchronous neoplasia in patients with flat adenomas. Gastrointest Endosc, 2016.
82. Weston BR. CME-Association between distal hyperplastic colon polyps and proximal lesions. Gastrointest Endosc, 2016.
83. Weston BR. CME-Diagnosis yield of EUS-guided FNA for malignant biliary stricture: A systematic review and meta-analysis. Gastrointest Endosc, 2016.
84. Weston BR. CME-Adenoma detection rate in high-risk patients. Gastrointest Endosc, 2016.
85. Weston BR. CME-EUS-guided drainage of pncreatic fluid collections using a novel lumen-apposing metal stent on an electrocautery-enhanced delivery system. Gastrointest Endosc, 2015.
86. Weston BR. CME-Metal versus plastic stents for pancreatic pseudocyst drainage. Gastrointest Endosc, 2015.
87. Weston BR. CME-EUS-guided pseudocyst drainage with fully covered self-expandable metal stents (FCSEMS). Gastrointest Endosc, 2015.
88. Weston BR. CME-Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc, 2015.
89. Weston BR. CME-Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc, 2015.
90. Weston BR. CME-Investigating endoscopic features of sessile serrated adenomas/polyps using narrow-band imaging with optical magnification. Gastrointest Endosc, 2015.
91. Weston BR. CME-Risk factors associated with post-ERCP pancreatitis in a pediatric population. Gastrointest Endosc, 2015.
92. Weston BR. CME-EUS-guided, through-the-needle confocal laser-induced endomicroscopy (nCLE) and cystoscopy for the diagnosis of pancreatic cystic neoplasms (PCN). Gastrointest Endosc, 2015.
93. Weston BR. CME-EUS-Guided biliary drainage (EUS-BD) as an alternative to ERCP in patients with malignant distal common bile duct obstruction. Gastrointest Endosc, 2015.
94. Weston BR. CME-Techniques to improve complete EMR of colorectal lesions. Gastrointest Endosc, 2015.
95. Weston BR. CME-EUS for locoregional evaluation of ampullary lesions. Gastrointest Endosc, 2015.
96. Weston BR. CME-Endoscopic ultrasound for the detection of pancreatic lesions in multiple endocrine neoplasia type 1 (MEN1) patients. Gastrointest Endosc, 2015.
97. Weston BR. CME-EUS-FNA for the diagnosis of pancreatic masses. Gastrointest Endosc, 2014.
98. Weston BR. CME-Endoscopic management of duodenal polyposis in patient with FAP. Gastrointest Endosc, 2014.
99. Weston BR. CME-The over-the scope clip (OTSC) for the management of gastrointestinal (GI) defects. Gastrointest Endosc, 2014.
100. Weston BR. CME-The Risk for advanced adenomas on the second surveillance colonoscopy in person with previous adenomatous polyps. Gastrointest Endosc, 2014.
101. Weston BR. CME-The Boston Bowel Preparation Scale (BBPS) as a standardized definition of "adequate" for describing bowel cleanliness. Gastrointest Endosc, 311, e1, 2014.
102. Weston BR. CME-EUS-FNA versus ERCP-based tissue sampling in evaluating suspected malignant biliary obstruction. Gastrointest Endosc, 2014.
103. Weston BR. CME-Endoscopic versus percutaneous drainage for the management of symptomatic pseudocysts. Gastrointest Endosc, 2014.
104. Weston BR. CME-Deep enteroscopy for small-bowel tumors. Gastrointest Endosc, 2014.
105. Weston BR. CME-Endocytoscopy of serrated polyps. Gastrointest Endosc, 2014.
106. Weston BR. CME-The accuracy of open forceps measurement of colorectal polyps. Gastrointest Endosc, 2014.
107. Weston BR. CME-The predictive value of cholangioscopic appearances of PCBS (post cholecystectomy bile duct strictures) after endotherapy with an increasing number of plastic stents. Gastrointest Endosc, 2014.
108. Weston BR. CME-Colectomy or repeat colonoscopy for patients with colon polyps referred for surgery. Gastrointest Endosc, 2014.
109. Weston BR. CME-Optical diagnosis of serrated lesions. Gastrointest Endosc, 2013.
110. Weston BR. CME-EUS-guided biliary drainage for malignant biliary drainage. Gastrointest Endosc, 2013.
111. Weston BR. CME-K-ras gene mutation analysis for the diagnosis of pancreatic adenocarcinoma during EUS-FNA. Gastrointest Endosc, 2013.
112. Weston BR. CME-Is there a predilection for cancer in Barrett's esophagus. Gastrointest Endosc, 2013.
113. Weston BR. CME-The emerging applications of FMT for the treatment of recurrent Clostridium difficile infection (CDI) and other disease processes. Gastrointest Endosc, 2013.
114. Weston BR. CME-Metal stents for benign biliary strictures. Gastrointest Endosc, 2013.
115. Weston BR. CME-Endoscopic features of sessile serrated adenomas. Gastrointest Endosc, 2013.
116. Weston BR. CME-EUS -guided pancreatic cyst ablation. Gastrointest Endosc, 2013.
117. Weston BR. CME-Proximal serrated polyp detection during screening colonoscopy. Gastrointest Endosc, 2013.
118. Weston BR. CME-Are clips useful in the prevention of delayed bleeding after endoscopic mucosal resection?. Gastrointest Endosc, 2013.

Editorials

1. Weston BR. Pancreatic steatosis: identification of yet another ‘new’ modifiable high-risk factor for post-ERCP pancreatitis?. Gastrointest Endosc 99(2):224-226, 2024. PMID: 38237965.
2. Weston BR, Ross WA. Quality metrics: Beyond adenoma detection rate. Gastrointest Endosc 85(3):588-9, 2017. PMID: 28215769.

Abstracts

1. Weston BR, Low D, Coronel, EC, Ge P, Ross WR, Lee JH. ERCP of uncertain benefit in cancer patients with large volume hepatic tumor burden: a tertiary referral cancer center experience. Endoscopy 55(S02):S162, 2023. e-Pub 2023.
2. Weston BR. EUS Detection of an inferior pancreatic-duodenal artery aneurysm Masquerading as a Hyper-Vascular Pancreatic Head Mass: Why Should We Care? American Journal of Gastroenterology 2021 Annual Meeting. ACG Abstract(116):S2483, 2021. e-Pub 2021.
3. Weston BR. Endoscopic Ultrasound-guided portal vein sampling of circulating tumor cells in pancreatic adenocarcinoma-a prospective randomized pilot study camparing a 22 and 19-gauge needle. DDW 2021(93):6S (ID: 3526877): AB230, 2021. e-Pub 2021.
4. Weston BR, Patel JM, Pande M, Lum PJ, Ross WA, Raju GS, Lynch PM, Coronel E, GE PS, Lee JH. Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstruction. Endoscopy 52((S 01)):S103, 2020. e-Pub 2020.
5. Weston BR, Ross WA, Bhutani MS, Lee JH, Pande M, Sholl AB, Krishnanurthi S. A prospective comparison study of a standard 25-gauge needle with a 22-gauge core needle using standard suction and capillary suction technique for cytologic and histologic EUS-sampling of solid pancreatic lesions. Gastrointest Endosc 81(5):AB542-AB543, 2015. e-Pub 2015.
6. Rahimi E, Weston B. Cholecystoduodenal fistula masquerading as a duodenal mass. Am J Gastroenterol 109((S2):1013), 2014. e-Pub 2014.
7. Rahimi E, Hofstetter W, Pinnix C, Thomas S, Loghavi S, Medeiros J, Weston B. Endoscopic mucosal resection (EMR) for the management of solitary extramedullary plasmacytoma of the esophagus. Am J Gastroenterol 109((S2):846), 2014. e-Pub 2014.
8. Weston BR, Ross WA, Lum P, Thirumurthi S, Miller ED, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Pande M, Asif R, Shafi MA, Shuttlesworth G, Stack RS, Mishra L, Stroehlein JR, Raju GS. Adenoma Detection Rate (ADR) and Serrated Adenoma Detection Rate (SDR) During Screening Colonoscopy with and without a Personal Cancer History (PCH) in a Tertiary Referral Cancer Center. Gastrointest Endosc 79(5):AB202, 2014. e-Pub 2014.
9. Sholl AB, Weston BR, Kundu UR, Ross WA, Bhutani MS, Lee JH, Krishnamurthy S. Emerging utility of the dual-use 22-gauge (Echotip Procore HD) biopsy needle for endoscopic ultrasound-guided cytologic and histologic sampling of pancreatic lesions. Journal of the American Society of Cytopathology 2(1:S1), 2013. e-Pub 2013.
10. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer (EC). ASCO 2012 Annual Meeting:e14547, 2012. e-Pub 2012.
11. Suzuki A, Xiao L, Taketa T, Blum MA, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Rice DC, Mehran RJ, Maru DM, Erasmus JJ, Hofstetter WL, Swisher S, Ajani JA. Customization of treatment for patients with esophageal adenocarcinoma (EAC) who achieve clinical complete response (cCR) after chemoradiation using initial standardized uptake value (iSUV) of 18f-fluorodeoxyglucose PET. ASCO 2012 Annual Meeting:ab 4069, 2012. e-Pub 2012.
12. Khanijow V, Adeyefa B, Machicado J, Kochar R, Shafi M, Weston B. Gastropericardial Fistula: A life threatening complication after esophagectomy. Am J Gastroenterol 107:S247, 2012. e-Pub 2012.
13. Atiq M, Lee JH, Ross WA, Weston BR, Stroehlein JR, Raju GS, Bhutani M. Is It Safe to Follow Cystic Pancreatic Neoplasms if Immediate Surgery Is. Am J Gastroenterol 106(S2):S67, AB169, 2011. e-Pub 2011.
14. Singh A, Ross WA, Lin Y, Atiq M, Davila M, Raju GS, Bhutani M, Lee JE, Fleming J, Weston BR, Lee JH. Outcomes of duodenal stent vs. gastrojejunostomy in patients with malignant gastric outlet obstruction - report from a tertiary care cancer clinic. Am J Gastroenterol 106(S2):S525, AB1371, 2011. e-Pub 2011.
15. Weston BR, Lee JH, Iyer RB, Ross WA. Clinical significance of incidental 18F-FDG uptake in the colon on PET/CT: Colonoscopic findings in a case control study. Gastrointest Endosc 67(5):AB82-83, 2008. e-Pub 2008.
16. Weston BR, Ross WA, Davila M, Lee JH. Clinical outcomes and performance of nitinol and stainless steel uncovered metal stents for malignant biliary strictures. Is there any difference?. Gastrointest Endosc 67(5):AB170, 2008. e-Pub 2008.
17. Weston BR, Ross WA, Lee JH. EUS guided transesophageal FNA in the evaluation of non-esophageal cancer related mediastinal lesions. Gastrointest Endosc 65(5):AB202, 2007. e-Pub 2007.
18. Weston BR, Ross WA, Lin E, Wang X, Lee JH. What happens to serum carbohydrate antigen 19-9 after biliary stent placement in pancreaticobiliary malignancy?. Am J Gastroenterol 101(S2):AB250, 2006. e-Pub 2006.
19. Weston BR, Ross WA, Xiao LC, Wang X, Wolff RA, Lee JH. Rate of bilirubin regression post-biliary stenting in malignant biliary obstruction for initiation of chemotherapy: How soon should we repeat ERCP?. Gastrointest Endosc 63(5):AB285, 2006. e-Pub 2006.
20. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley C, Coates M, Strahl E, Rex DK. Nurse administered propofol versus midazolam and meperidine for diagnostic upper endoscopy in cirrhotic patients. Am J Gastroenterol 98(9S):AB891, 2003. e-Pub 2003.

Book Chapters

1. Mahajan S, Weston BR, Kongkam P, Bhutani MS. Colorectal EUS. In: Endoscopic: Ultrasonography. 4th Edition. John Wiley & Sons Ltd, 207 - 222, 2024.
2. Weston BR, Coronel ES. Diagnosis and staging of pancreatic cancer; role of gastroenterologist, EUS guided biopsy in Pancreatic cancer: a multidisciplinary approach & emerging paradigms. In: Pancreatic Cancer: A Multidisciplinary Approach. Springer Nature, 77 -89, 2022.
3. Bhutani MS, Weston BR, Kongkam P. Colorectal Endoscopic Ultrasound. In: Endoscopic Ultrasonography. 3rd Editiion. John Wiley and Sons Ltd, 2016.
4. Weston BR, Ko C. Biliary tract disease in pregnancy. In: Complications of Pregnancy. 6th. PMPH-USA Ltd, 2013.
5. Weston BR, Bhutani MS. Endoscopic Ultrasound (EUS) in Inflammatory Bowel Disease (IBD). In: EUS Pathology with Digital Anatomy Correlation. People's Medical Publishing House, 397-400, 2010.
6. Weston BR, Bhutani MS. Ovarian and Gynecological Lesions. In: EUS Pathology with Digital Anatomy Correlation. People's Medical Publishing House, 369-374, 2010.
7. Weston BR, Coronel ES. Diagnosis and staging of pancreatic cancer; role of gastroenterologist, EUS guided biopsy in Pancreatic cancer: a multidisciplinary approach & emerging paradigms. In: Springer Nature.